Sangeeta Bhatia

John J. and Dorothy Wilson Professor of Health Sciences and Technology and of Electrical Engineering and Computer Science
Massachusetts Institute of Technology

Sangeeta Bhatia earned her BS at Brown University, followed by an MS in Mechanical Engineering at MIT, a PhD in Biomedical Engineering at the Harvard-MIT Division of Health Sciences and Technology, and an MD at Harvard Medical School. Prior to her appointment at MIT, Bhatia held a tenured position at UCSD. She and her trainees have launched multiple biotechnology companies to improve human health. As a prolific inventor and passionate advocate for diversity in science and engineering, Bhatia has received many honors including the Lemelson-MIT Prize, known as the “Oscar for inventors,” and the Heinz Medal for groundbreaking inventions and advocacy for women in STEM fields. She is a Howard Hughes Medical Institute Investigator, Director of the Marble Center for Cancer Nanomedicine at the Koch Institute for Integrative Cancer Research at MIT, and an elected member of the National Academy of Sciences, the National Academy of Engineering, the National Academy of Medicine, the American Academy of Arts and Science, the National Academy of Inventors, and Brown University's Board of Fellows.

Bhatia is a board member of Brown University, Vertex Pharmaceuticals,* Port Therapeutics,* Ropirio Therapeutics.* She has an advisory role with Global Oncology Inc., Sunbird BIO,* Satellite Bio,* Matrisome Bio,* Xilio Therapeutics, Danaher, Ochre Bio,* Amplifyer Bio,* Earli Inc.,* Brigham Research Institute/Brigham and Women’s Hospital, and Impilo Therapeutics.*

*Dr. Sangeeta Bhatia holds equity in these institutions